acquired
Stage
2016
Founded
3
Investors
About
Dewpoint Therapeutics is developing a drug platform that targets biomolecular condensates to create new therapies for difficult-to-treat diseases.
Explore Dewpoint Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.